EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

TFE3 fusion proteins promoted the progression of Xp11.2 translocation renal cell carcinoma through post-translational modification of PDL1 by upregulating CCND1/Cyclin D1

Yanwen Lu, Yi Chen, Xinghe Pan, Wenliang Ma, Ning Liu, Lei Yang, Xiang Dong, Hongqian Guo, Dongmei Li, Weidong Gan

Cellular Oncology · 2025

DOI: 10.1007/s13402-025-01125-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2025. Verfasst von Yanwen Lu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, Jiangsu, 210093, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Cyclin D1, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Research Project of Jiangsu Commission of Health, Natural Science Foundation of Jiangsu Province, Beijing Ronghe Medical Development Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsCyclin D1Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsTranslocation, GeneticUp-RegulationB7-H1 AntigenOncogene Proteins, FusionProtein Processing, Post-TranslationalDisease ProgressionHumansCell Line, TumorGene Expression Regulation, NeoplasticAutophagyMaleSignal Transduction

Stichwörter der Autor:innen

CCND1/Cyclin D1CDK4 inhibitorsPDL1TFE3 fusion proteinsXp11.2 tRCC

Substanzen

Cyclin D1TFE3 protein, humanBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsB7-H1 AntigenOncogene Proteins, FusionCD274 protein, humanCCND1 protein, human

Autor:innen und Institutionen

  • Department of Urology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, Jiangsu, 210093, China.
  • Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Department of Cardiology, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210008, China.
  • Department of Urology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medical, Nanjing, Jiangsu, 210008, China.
  • Department of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210001, China.
  • Clinical and Translational Research Center, Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu, 226001, China.

Förderung

  • Medical Research Project of Jiangsu Commission of Health
  • Natural Science Foundation of Jiangsu Province
  • Beijing Ronghe Medical Development Foundation

Zitieren

APA

Lu, Y., Chen, Y., Pan, X., Ma, W., Liu, N., Yang, L., Dong, X., Guo, H., Li, D., & Gan, W. (2025). TFE3 fusion proteins promoted the progression of Xp11.2 translocation renal cell carcinoma through post-translational modification of PDL1 by upregulating CCND1/Cyclin D1. Cellular Oncology. https://doi.org/10.1007/s13402-025-01125-x

Vancouver

Lu Y, Chen Y, Pan X, Ma W, Liu N, Yang L, et al. TFE3 fusion proteins promoted the progression of Xp11.2 translocation renal cell carcinoma through post-translational modification of PDL1 by upregulating CCND1/Cyclin D1. Cellular Oncology. 2025. doi:10.1007/s13402-025-01125-x

BibTeX
@article{Lu2025,
  author = {Lu, Yanwen and Chen, Yi and Pan, Xinghe and Ma, Wenliang and Liu, Ning and Yang, Lei and Dong, Xiang and Guo, Hongqian and Li, Dongmei and Gan, Weidong},
  title = {TFE3 fusion proteins promoted the progression of Xp11.2 translocation renal cell carcinoma through post-translational modification of PDL1 by upregulating CCND1/Cyclin D1},
  journal = {Cellular Oncology},
  year = {2025},
  doi = {10.1007/s13402-025-01125-x}
}
Kostenlos starten →